| 前收市價 | 90.00 |
| 開市 | 90.13 |
| 買盤 | 89.50 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 89.10 - 90.30 |
| 52 週波幅 | 79.21 - 94.52 |
| 成交量 | |
| 平均成交量 | 3,346,228 |
| 市值 | 182.617B |
| Beta 值 (5 年，每月) | 0.47 |
| 市盈率 (最近 12 個月) | 22.21 |
| 每股盈利 (最近 12 個月) | 4.03 |
| 業績公佈日 | 2024年7月18日 |
| 遠期股息及收益率 | 3.30 (3.69%) |
| 除息日 | 2024年3月07日 |
| 1 年預測目標價 | 86.92 |
ZacksPharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Investor's Business DailyWhy Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.
Insider MonkeyNovartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2024 Results Release Conference Call and Live Webcast. […]
